Last reviewed · How we verify
Varenicline Tartrate Controlled Release
Varenicline Tartrate Controlled Release is a Small molecule drug developed by Pfizer. It is currently in Phase 1 development.
At a glance
| Generic name | Varenicline Tartrate Controlled Release |
|---|---|
| Sponsor | Pfizer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial (PHASE4)
- Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use (NA)
- Aggressive Smoking Cessation Trial (ASAP) (PHASE3)
- So-Lo-Mo Intervention Applied to the Smoking Cessation Process (NA)
- Early In-hospital Initiation of Pharmacotherapy for Smoking Cessation, Patients After ACS (NA)
- A Study to Evaluate the Safety and Efficacy of Three Doses of a Controlled Release Formulation of Varenicline for Smoking Cessation (PHASE2)
- An Investigation Of The Effects Of Food On The Absorption Of A Varenicline Controlled Release Formulation (PHASE1)
- Multiple Dose, Dose Escalation Study of Varenicline Controlled Release Formulation in Adult Smokers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Varenicline Tartrate Controlled Release CI brief — competitive landscape report
- Varenicline Tartrate Controlled Release updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Varenicline Tartrate Controlled Release
What is Varenicline Tartrate Controlled Release?
Varenicline Tartrate Controlled Release is a Small molecule drug developed by Pfizer.
Who makes Varenicline Tartrate Controlled Release?
Varenicline Tartrate Controlled Release is developed by Pfizer (see full Pfizer pipeline at /company/pfizer).
What development phase is Varenicline Tartrate Controlled Release in?
Varenicline Tartrate Controlled Release is in Phase 1.